7210 Wareham Drive, Tampa, FL 33647
Sept. 13, 2023 On August 8, Lilly reported that its second-quarter income jumped 85% from the same period a year ago, driven in large part by Mounjaro, which generated $979.7 million in sales for the quarter, compared to $16 million in the year-ago period and $569 million in the first quarter of this year. In …
Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a …
Aug. 5, 2023 WW reported its second quarter results yesterday. End of Period Subscribers of 4.1 million Revenues of $226.8 million Operating Income of $26.3 million; excluding the net impact of restructuring charges and acquisition transaction costs, adjusted operating income of $33.9 million Full Year Fiscal 2023 Guidance: Revenues are expected to be in the …
Weight Watchers Reports 2nd Quarter 2023 Results Read More »
June 5, 2023 There is no doubt that the new obesity drugs (Wegovy, Ozempic) are hot and in high demand, but there is a disturbing new trend developing. Since the brand name drugs often cost $1,000 to $1,300 per month and are not covered by insurance, people are looking for cheaper alternatives. That’s where compounding …
Semaglutide Gold Rush Is On, Compounding Pharmacies Read More »
April 19, 2023 We obtained some information regarding Noom’s participation in the medical weight loss arena. “…Noom Clinical is offered to adults (18+) that are over BMI 30 or, BMI 27 and above with obesity-related conditions. Individual eligibility for specific options is determined by our trained clinicians and overseen by our Chief of Medicine. With …
March 7, 2023 Weight Watchers has entered into a definitive agreement to acquire Weekend Health, Inc., d/b/a Sequence, a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management via the use of medications. Sequence seamlessly integrates the patient and clinician experience for ongoing, clinical care and medication management while providing high-touch support …
Jan. 9, 2023 HMR (Health Management Resources), the weight loss program offered for the past 40 years in hospitals, clinics, and MD offices, was recently sold to Sanford Health, which runs the Profile by Sanford weight loss program. HMR has offered both medical and non-medical programs to consumers. In 2023, HMR programs and services will …
Sept. 3, 2022 Found Health is a new weight loss company that claims to offer a science-backed solution for personalized, lasting weight care that addresses the missing link in the existing weight loss market: biology. Found is a direct-to-consumer healthcare company with a focus on supporting your weight loss journey holistically, based on the science of …
March 5, 2022 Marketdata’s new report, The U.S. Weight Loss Market: 2022 Status Report & Forecast (March 2022, 90 pp.) has just been released. Major Findings: The value of the U.S. weight loss market is estimated to have declined by a historic 25% in 2020, to $58 billion. as a result of closures of weight loss centers and …
Weight Loss Market Rebounds in 2021 From 25% Decline in 2020 – New Report Read More »
Dec. 30, 2021 2021 was a historic year for obesity treatment. In June, the Food and Drug Administration approved the weight loss drug semaglutide, which some experts described as a “game changer”. The medication, initially developed to treat Type 2 diabetes, was the first drug treatment to be approved by the FDA for weight management since 2014. Wegovy, …